Korro Bio (KRRO) Total Liabilities (2018 - 2026)

Korro Bio's Total Liabilities history runs 9 years deep, the most recent figure standing at $64.0 million for Q1 2026.

• Quarterly Total Liabilities rose 1.17% year-over-year to $64.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.0 million (up 1.17% YoY) and the FY2025 annual result came in at $62.1 million, down 5.71% from the prior year.
• Total Liabilities was $64.0 million for Q1 2026 at Korro Bio, up from $62.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $65.8 million in Q4 2024 and bottomed at $8.9 million in Q4 2022.
• A 5-year average of $50.4 million and a median of $53.8 million in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities slumped 83.66% — and 2024, when it surged 564.91%.
• Korro Bio's Total Liabilities stood at $8.9 million in 2022, then jumped by 480.83% to $51.8 million in 2023, then climbed by 27.19% to $65.8 million in 2024, then decreased by 5.71% to $62.1 million in 2025, then grew by 3.1% to $64.0 million in 2026.
• Business Quant data shows KRRO's Total Liabilities at $64.0 million in Q1 2026, $62.1 million in Q4 2025, and $62.5 million in Q3 2025.